Use of Tandem Mass Spectrometry for Newborn Screening of 6 Lysosomal Storage Disorders in a Korean Population
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: We evaluated the performance of multiplex tandem mass spectrometry (MS/MS) in newborn screening for detection of 6 lysosomal storage disorders (LSDs), namely, Niemann-Pick A/B, Krabbe, Gaucher, Fabry, and Pompe diseases and Hurler syndrome. Methods: We revised the conditions and procedures of multiplex enzyme assay for the MS/MS analysis and determined the precision of our enzyme assay and the effects of sample amounts and incubation time on the results. We also measured the degree of correlation between the enzyme activities in the dried blood spots (DBSs) and those in the leukocytes. DBSs of 211 normal newborns and 13 newborns with various LSDs were analyzed using our revised methods. Results: The intra- and inter-assay precisions were 2.9-18.7% and 8.1-18.1%, respectively. The amount of product obtained was proportional to the DBS eluate volume, but a slight flattening was observed in the product vs. sample volume curve at higher sample volumes. For each enzyme assay, the amount of product obtained increased linearly with the incubation period (range, 0-24 hr). Passing and Bablok regression analysis revealed that the enzyme activities in the DBSs and those in the leukocytes were favorably correlated. The enzyme activities measured in the DBSs were consistently lower in patients with LSDs than in normal newborns. Conclusions: The performance of our revised techniques for MS/MS detection and enzyme assays was of the generally acceptable standard. To our knowledge, this is the first report on the use of MS/MS for newborn screening of LSDs in an Asian population.
Abstract
Background: We evaluated the performance of multiplex tandem mass spectrometry (MS/MS) in newborn screening for detection of 6 lysosomal storage disorders (LSDs), namely, Niemann-Pick A/B, Krabbe, Gaucher, Fabry, and Pompe diseases and Hurler syndrome. Methods: We revised the conditions and procedures of multiplex enzyme assay for the MS/MS analysis and determined the precision of our enzyme assay and the effects of sample amounts and incubation time on the results. We also measured the degree of correlation between the enzyme activities in the dried blood spots (DBSs) and those in the leukocytes. DBSs of 211 normal newborns and 13 newborns with various LSDs were analyzed using our revised methods. Results: The intra- and inter-assay precisions were 2.9-18.7% and 8.1-18.1%, respectively. The amount of product obtained was proportional to the DBS eluate volume, but a slight flattening was observed in the product vs. sample volume curve at higher sample volumes. For each enzyme assay, the amount of product obtained increased linearly with the incubation period (range, 0-24 hr). Passing and Bablok regression analysis revealed that the enzyme activities in the DBSs and those in the leukocytes were favorably correlated. The enzyme activities measured in the DBSs were consistently lower in patients with LSDs than in normal newborns. Conclusions: The performance of our revised techniques for MS/MS detection and enzyme assays was of the generally acceptable standard. To our knowledge, this is the first report on the use of MS/MS for newborn screening of LSDs in an Asian population.
참고문헌 (15)
- Futerman AH, "The cell biology of lysosomal storage disorders", Nat Rev Mol Cell Biol, 5, pp.554~565 (2004)
- Meikle PJ, "Prevalence of lysosomal storage disorders", JAMA, 281, pp.249~254 (1999)
- Chace DH, "Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns", Clin Chem, 49, pp.1797~1817 (2003)
- Lehotay DC, "LC-MS", MS progress in newborn screening, 2011, pp.44, 21~31
- Ko DH, "Multiplex enzyme assay for galactosemia using ultraperformance liquid chromatography-tandem mass spectrometry", Clin Chem, 56, pp.764~771 (2010)
- Ko DH, "Newborn screening for galactosemia by a second-tier multiplex enzyme assay using UPLC-MS", MS in dried blood spots, 2011, pp.34, 409~414
- Li Y, "Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening", Clin Chem, 50, pp.1785~1796 (2004)
- Zhang XK, "Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry", Clin Chem, 54, pp.1725~1728 (2008)
- Chamoles NA, "Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis", Clin Chem, 47, pp.780~781 (2001)
- Wang D, "Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns", Clin Chem, 51, pp.898~900 (2005)
- Blanchard S, "Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I", Clin Chem, 54, pp.2067~2070 (2008)
- Duffey TA, "A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler)", Clin Chem, 56, pp.1854~1861 (2010)
- Duffey TA, "Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)", Anal Chem, 82, pp.9587~9591 (2010)
- Khaliq T, "Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA", Clin Chem, 57, pp.128~131 (2011)
- Wolfe BJ, "Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome)", Anal Chem, 83, pp.1152~1156 (2011)